psylo_newsletters Guest User 5/11/24 psylo_newsletters Guest User 5/11/24 Neuroscience Newsletter - 2024 October Read More psylo_news Dilara Bahceci 28/10/24 psylo_news Dilara Bahceci 28/10/24 $3M grant to accelerate development of neuroplastogens for substance use disorder treatment Read More psylo_news Dilara Bahceci 25/10/24 psylo_news Dilara Bahceci 25/10/24 $6 million boost for industry research projects Read More psylo_newsletters Guest User 8/10/24 psylo_newsletters Guest User 8/10/24 Neuroscience Newsletter - 2024 September Read More psylo_news Dilara Bahceci 18/9/24 psylo_news Dilara Bahceci 18/9/24 How Psylo and Enosis Therapeutics are using tech to tackle medicinal psychedelics Read More psylo_newsletters Guest User 9/9/24 psylo_newsletters Guest User 9/9/24 Neuroscience Newsletter - 2024 August Read More psylo_newsletters Guest User 3/8/24 psylo_newsletters Guest User 3/8/24 Neuroscience Newsletter - 2024 July Read More psylo_newsletters Guest User 2/7/24 psylo_newsletters Guest User 2/7/24 Neuroscience Newsletter - 2024 June Read More psylo_news Dilara Bahceci 27/6/24 psylo_news Dilara Bahceci 27/6/24 Psylo partnership to deliver psychedelic treatments for mental health Read More psylo_news Dilara Bahceci 24/6/24 psylo_news Dilara Bahceci 24/6/24 Psylo's US trip: why the psychedelics startup is keeping one foot in Australia as it expands stateside Read More psylo_news Dilara Bahceci 22/6/24 psylo_news Dilara Bahceci 22/6/24 Next-generation psychedelics: should new agents skip the trip? Read More psylo_news Dilara Bahceci 4/6/24 psylo_news Dilara Bahceci 4/6/24 Superseeder: psychedelic biotech Psylo plants $12 million in latest ‘Seed’ round Read More psylo_news Dilara Bahceci 4/6/24 psylo_news Dilara Bahceci 4/6/24 Next-generation psychedelics: should new agents skip the trip? Read More psylo_news Dilara Bahceci 3/6/24 psylo_news Dilara Bahceci 3/6/24 Psylo Announces First Close on $8 Million Series Seed Financing to Advance Next-Generation Neuroplastogens Read More psylo_newsletters Guest User 2/6/24 psylo_newsletters Guest User 2/6/24 Neuroscience Newsletter - 2024 May Read More psylo_newsletters Guest User 6/5/24 psylo_newsletters Guest User 6/5/24 Psychedelic Science Newsletter - 2024 April Read More psylo_newsletters Guest User 1/4/24 psylo_newsletters Guest User 1/4/24 Psychedelic Science Newsletter - 2024 March Read More psylo_newsletters Guest User 3/3/24 psylo_newsletters Guest User 3/3/24 Psychedelic Science Newsletter - 2024 February Read More psylo_news Dilara Bahceci 1/3/24 psylo_news Dilara Bahceci 1/3/24 Dr. Sam Banister – Drug Development, Biotech, and Exploring Non-Hallucinogenic Compounds (PT491) Read More psylo_news Dilara Bahceci 13/2/24 psylo_news Dilara Bahceci 13/2/24 PSYLO's Next Generation Psychedelic Pipeline: An Interview with CSO and Co-founder Sam Banister Read More Older Posts
psylo_newsletters Guest User 5/11/24 psylo_newsletters Guest User 5/11/24 Neuroscience Newsletter - 2024 October Read More
psylo_news Dilara Bahceci 28/10/24 psylo_news Dilara Bahceci 28/10/24 $3M grant to accelerate development of neuroplastogens for substance use disorder treatment Read More
psylo_news Dilara Bahceci 25/10/24 psylo_news Dilara Bahceci 25/10/24 $6 million boost for industry research projects Read More
psylo_newsletters Guest User 8/10/24 psylo_newsletters Guest User 8/10/24 Neuroscience Newsletter - 2024 September Read More
psylo_news Dilara Bahceci 18/9/24 psylo_news Dilara Bahceci 18/9/24 How Psylo and Enosis Therapeutics are using tech to tackle medicinal psychedelics Read More
psylo_newsletters Guest User 9/9/24 psylo_newsletters Guest User 9/9/24 Neuroscience Newsletter - 2024 August Read More
psylo_newsletters Guest User 3/8/24 psylo_newsletters Guest User 3/8/24 Neuroscience Newsletter - 2024 July Read More
psylo_newsletters Guest User 2/7/24 psylo_newsletters Guest User 2/7/24 Neuroscience Newsletter - 2024 June Read More
psylo_news Dilara Bahceci 27/6/24 psylo_news Dilara Bahceci 27/6/24 Psylo partnership to deliver psychedelic treatments for mental health Read More
psylo_news Dilara Bahceci 24/6/24 psylo_news Dilara Bahceci 24/6/24 Psylo's US trip: why the psychedelics startup is keeping one foot in Australia as it expands stateside Read More
psylo_news Dilara Bahceci 22/6/24 psylo_news Dilara Bahceci 22/6/24 Next-generation psychedelics: should new agents skip the trip? Read More
psylo_news Dilara Bahceci 4/6/24 psylo_news Dilara Bahceci 4/6/24 Superseeder: psychedelic biotech Psylo plants $12 million in latest ‘Seed’ round Read More
psylo_news Dilara Bahceci 4/6/24 psylo_news Dilara Bahceci 4/6/24 Next-generation psychedelics: should new agents skip the trip? Read More
psylo_news Dilara Bahceci 3/6/24 psylo_news Dilara Bahceci 3/6/24 Psylo Announces First Close on $8 Million Series Seed Financing to Advance Next-Generation Neuroplastogens Read More
psylo_newsletters Guest User 2/6/24 psylo_newsletters Guest User 2/6/24 Neuroscience Newsletter - 2024 May Read More
psylo_newsletters Guest User 6/5/24 psylo_newsletters Guest User 6/5/24 Psychedelic Science Newsletter - 2024 April Read More
psylo_newsletters Guest User 1/4/24 psylo_newsletters Guest User 1/4/24 Psychedelic Science Newsletter - 2024 March Read More
psylo_newsletters Guest User 3/3/24 psylo_newsletters Guest User 3/3/24 Psychedelic Science Newsletter - 2024 February Read More
psylo_news Dilara Bahceci 1/3/24 psylo_news Dilara Bahceci 1/3/24 Dr. Sam Banister – Drug Development, Biotech, and Exploring Non-Hallucinogenic Compounds (PT491) Read More
psylo_news Dilara Bahceci 13/2/24 psylo_news Dilara Bahceci 13/2/24 PSYLO's Next Generation Psychedelic Pipeline: An Interview with CSO and Co-founder Sam Banister Read More
